Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
20.28
-0.37 (-1.79%)
At close: Dec 5, 2025, 4:00 PM EST
20.17
-0.11 (-0.57%)
After-hours: Dec 5, 2025, 5:23 PM EST
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $2.90 billion as of December 5, 2025. Its market cap has decreased by -2.99% in one year.
Market Cap
2.90B
Enterprise Value
2.23B
1-Year Change
-2.99%
Ranking
Category
Stock Price
$20.28
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $2.90B, an increase of 266.23%. That is a compound annual growth rate of 28.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 2.95B | 23.01% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |